The treatment of skin immune diseases is one of the most successful cases in immunological translational medicine. Previously, the treatment of immune diseases was mainly achieved through the accidental discovery of drugs or therapies, which often had poor efficacy and certain toxicity in long-term treatment.

         With the application of biologics, more and more patients with immune diseases are achieving the treatment goal of improving symptoms such as skin lesions, itching, and pain. We still have many questions regarding the pharmaceutical mechanisms of biologics, rational and safe use of drugs, long-term patient management, early intervention, and other aspects. In order to promote the development of immune diseases, psoriasis, urticaria, atopic dermatitis and other fields, improve the level of precision diagnosis and treatment, use biological agents reasonably and safely, manage chronic diseases throughout the process, and reduce the burden of patients' diseases, the Academic Conference on Standardized Diagnosis and Treatment of Skin Immune Diseases sponsored by Chengdu High tech Medical Association was successfully held online on December 16, 2024.